After years of living in biopharma’s shadow, the cleantech sector is showing encouraging signs of life. New cleantech start-ups are popping up, and angel investors are again interested in investing in the promise of clean energy. According to the Propel(x) Survey of Angels, more than half reported that they are interested in the sector. That’s a far cry from the early 2000s, when cleantech was avoided by the investment community. Still, whether biopharma or cleantech, promising new ideas can take years to grow into viable offerings — not to mention large amounts of capital for conducting research, building infrastructure, and establishing distribution networks. That’s where cleantech could benefit by borrowing a few pages from the biopharma playbook
How Can Cleantech Companies Fast-Track The Path To Success? Borrow From Biopharma’s Playbook. was originally published on CleanTechnica.
To read more from CleanTechnica, join over 50,000 other subscribers: Google+ | Email | Facebook | RSS | Twitter.